DPP-4 INHIBITION ATTENUATES CARDIAC DYSFUNCTION AND ADVERSE REMODELLING FOLLOWING MYOCARDIAL INFARCTION IN EXPERIMENTAL DIABETES

被引：1
|
作者：
Connelly, K. A.
Desjardins, J.
Advani, A.
Kabir, G.
Zhang, Y.
Advani, S. L.
Yuen, D. A.
Thai, K.
Gilbert, R. E.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2011年 / 27卷 / 05期
关键词：
D O I：
10.1016/j.cjca.2011.07.597
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S328 / S328
页数：1
相关论文
共 50 条
  • [41] Roxadustat Attenuates Adverse Remodeling Following Myocardial Infarction in Mice
    Zaruba, Marc-Michael
    Staggl, Simon
    Ghadge, Santhosh Kumar
    Maurer, Thomas
    Gavranovic-Novakovic, Jasmina
    Jeyakumar, Vivek
    Schoenherr, Patric
    Wimmer, Andreas
    Poelzl, Gerhard
    Bauer, Axel
    Messner, Moritz
    CELLS, 2024, 13 (13)
  • [42] DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus
    Kanazawa, Ippei
    Tanaka, Ken-ichiro
    Sugimoto, Toshitsugu
    MEDICAL SCIENCE MONITOR, 2014, 20 : 1662 - 1667
  • [43] Diastolic dysfunction and adverse diastolic remodelling as predictors of infarct scar and cardiovascular events following acute myocardial infarction
    Nguyen, T. L.
    Phan, J.
    Hogan, J.
    Hee, L.
    Juergens, C.
    Rajaratnam, R.
    Dimitri, H.
    French, J.
    Richards, D.
    Thomas, L.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1021 - 1021
  • [44] Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction
    Ni T.
    Huang X.
    Pan S.
    Lu Z.
    Oxidative Medicine and Cellular Longevity, 2021, 2021
  • [45] Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
    Zhong, Peng
    Zhang, Jingjing
    Wei, Yanzhao
    Liu, Tao
    Chen, Minxiao
    HELIYON, 2023, 9 (11)
  • [46] Dipeptidyl peptidase IV (DPP-4) inhibition as a treatment for type 2 diabetes
    Thornberry, Nancy A.
    TUMOR BIOLOGY, 2007, 28 : 26 - 26
  • [47] Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes
    Pratley, Richard E.
    Salsali, Afshin
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 919 - 931
  • [48] Delayed, oral pharmacological inhibition of calpains attenuates adverse post-infarction remodelling
    Poncelas, Marcos
    Inserte, Javier
    Aluja, David
    Hernando, Victor
    Vilardosa, Ursula
    Garcia-Dorado, David
    CARDIOVASCULAR RESEARCH, 2017, 113 (08) : 950 - 961
  • [49] Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
    Berezin, Alexander E.
    Berezin, Alexander A.
    DISEASE MARKERS, 2020, 2020
  • [50] Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction
    Kim A. Connelly
    Yanling Zhang
    Jean-François Desjardins
    Kerri Thai
    Richard E. Gilbert
    Cardiovascular Diabetology, 17
12345